Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives

A Shinde, K Panchal, S Katke, R Paliwal, A Chaurasiya - Therapies, 2022 - Elsevier
Protein kinases, a class of enzymes that govern various biological phenomena at a cellular
level, are responsible for signal transduction in cells that regulate cellular proliferation …

Current progress towards the development of tyrosine kinase inhibitors as anticancer agents

AJ Bridges - Emerging drugs, 1998 - Taylor & Francis
Tyrosine kinases (TKs) are a large subfamily of the largest known gene family, the kinases,
of which the human genome is now estimated to contain in excess of 2,000 [1]. TKs catalyse …

[HTML][HTML] Utilization of kinase inhibitors as novel therapeutic drug targets: A review

S Nishal, V Jhawat, S Gupta, P Phaugat - Oncology research, 2022 - ncbi.nlm.nih.gov
Kinase inhibitors are a significant and continuously developing division of target
therapeutics. The drug discovery and improvement efforts have examined numerous …

Receptor tyrosine kinases and anticancer therapy

M Medinger, J Drevs - Current pharmaceutical design, 2005 - ingentaconnect.com
Receptor and non-receptor protein tyrosine kinases (PTKs) are essential enzymes in cellular
signaling processes and signal transduction pathways that regulate cell growth …

Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer

Y Zhao, M Bilal, A Raza, MI Khan, S Mehmood… - International journal of …, 2021 - Elsevier
Cancer is one of the leading causes of death with a mortality rate of 12%. Although
significant progress has been achieved in cancer research, the effective treatment of cancer …

Overcoming the drug resistance problem with second-generation tyrosine kinase inhibitors: from enzymology to structural models

E Crespan, E Zucca, G Maga - Current medicinal chemistry, 2011 - ingentaconnect.com
Protein phosphorylation is one of the major pathways used by eukaryotic cells to propagate
signals to the final effectors, regulating multiple aspects of the living cell, such as …

Role of tyrosine kinase inhibitors in cancer therapy

A Arora, EM Scholar - Journal of Pharmacology and Experimental …, 2005 - ASPET
Cancer chemotherapy has been one of the major medical advances in the last few decades.
However, the drugs used for this therapy have a narrow therapeutic index, and often the …

Cancer management by tyrosine kinase inhibitors: efficacy, limitation, and future strategies

VWT Ho, HY Tan, N Wang, Y Feng - Tyrosine Kinases as …, 2019 - books.google.com
Tyrosine kinase inhibitors are taking up an increasingly significant role in treating cancers.
There are different types of TKIs currently used in clinical settings. However, TKI-associated …

[PDF][PDF] Tyrosine Kinases: promising targets for cancer chemotherapy

VS Kasture, DS Musmade, SJ Aher… - Med Chem Drug Discov, 2012 - academia.edu
Cancer chemotherapy has been one of the major medical advances in the last few decades.
However, the drugs used for this therapy have a narrow therapeutic index, and often the …

Tyrosine kinase inhibitors in cancer therapy

S Madhusudan, TS Ganesan - Clinical biochemistry, 2004 - Elsevier
Cancer is the second leading cause of death in the western world. Despite advances in
diagnosis and treatment, overall survival of patients remains poor. Scientific advances in …